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Abstract: A significant symptom of Lewy body dementia (LBD) is slow cognitive processing or brady-
phrenia. In a previous fMRI task-based study, we found slower responses in LBD, accompanied by
greater deactivation in the default mode network. In this study, we investigated the timing and magni-
tude of the activations and deactivations with respect to reaction time to determine whether the slower
responses in LBD were associated with delayed neuronal activity. Using fMRI, we examined the magni-
tude and latency of activations and deactivations during an event-related attention task in 32 patients
with LBD and 23 healthy controls using predefined regions of interest. Default mode network deactiva-
tions did not significantly differ in their timing between groups or task conditions, while the task-
related activations in the parietal, occipital, frontal, and motor cortex were all significantly later in the
LBD group. Repeating the analysis with reaction time as a parametric modulator of activation magni-
tude produced similar findings, with the reaction time modulator being significant in a number of
regions including the default mode network, suggesting that the increased deactivation in LBD is partly
explained by slower task completion. Our data suggest that the default mode network deactivation is
initiated at the start of the task, and remains deactivated until its end, with the increased magnitude of
deactivation in LBD reflecting the more prolonged cognitive processing in these patients. These data
add substantially to our understanding of the neural origins of bradyphrenia, which will be essential
for determining optimum therapeutic strategies for cognitive impairment in LBD. Hum Brain Mapp
39:633–643, 2018. VC 2017 The Authors Human Brain Mapping Published by Wiley Periodicals, Inc.
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INTRODUCTION
Lewy body dementia (LBD) includes both dementia with
Lewy bodies and Parkinson’s disease dementia, and is a
major cause of dementia after Alzheimer’s disease,
representing 4–8% of all late onset dementia cases (Vann
Jones and O’Brien, 2014). LBD is characterized by fluctua-
tions in cognition, spontaneous motor features of parkinson-
ism, and complex visual hallucinations, and a wide array of
other symptoms (Emre et al., 2007; McKeith et al., 2005).
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Deficits in attention and executive functioning are also a
common feature in Lewy body dementia (Baddeley et al.,
2001; Ballard et al., 2002; Ferman et al., 2006; Metzler-
Baddeley, 2007) and, in particular, cognitive slowing (or bra-
dyphrenia) has been reported in both Parkinson’s disease
and Lewy body dementia, with slower response times in
tasks, even after accounting for bradykinesia (motor slow-
ing), as well as reduced information processing capability
(Bailon et al., 2010; Bradshaw et al., 2006; Johnson et al.,
2004; Sawamoto et al., 2002). Slow response times are associ-
ated with increased fluctuations in attention (Ballard et al.,
2001), which has adverse effects on patient’s and carer’s
quality of life (Bronnick et al., 2006; Lee et al., 2013). It has
been suggested that bradyphrenia may be in part due to
dopaminergic deficits in the basal ganglia (Jokinen et al.,
2013), which play a role in determining the salience of, and
reward associated with stimuli (Matsumoto, 2015). In addi-
tion the nicotinic receptors in the cholinergic system modu-
late information processing speed (Schneider et al., 2015;
Wesnes and Warburton, 1984) and given the cholinergic sys-
tem is profoundly affected in LBD (Bohnen et al., 2003; Tira-
boschi et al., 2002) it is possible that dysfunction of this
system may also play a role in slow cognitive speed in LBD.
However, there is relatively little published research on the
origins or neural correlates of cognitive slowing in LBD.
In a recent study (Firbank et al., 2016) using a version of
the attention network task (ANT), we found slower reac-
tion times in LBD compared to healthy controls, with
increasing response latency for harder trials. In the LBD
patients there was only limited evidence on fMRI analysis
of increases in task-related activations during more diffi-
cult aspects of the task. We hypothesized that the lack of
increased BOLD activation suggested an absence of com-
pensatory brain activity, and that the slower response was
thus driven by delays in brain activation due to slower
cognitive processing.
Subjects with LBD did, however, have significantly
greater deactivation in the default mode network (DMN).
This network, which includes the posterior cingulate,
lateral parietal lobe and medial prefrontal cortex, is a
network of regions which show high activity during rest,
but decreased activity during a range of externally
directed cognitive tasks. The DMN regions are thought to
be involved in cognitive processes including episodic
memory, internally directed attention and mind wander-
ing (Andrews-Hanna, 2012; Buckner et al., 2008). The deac-
tivation of the DMN during tasks is believed to represent
a decrease in internally directed thoughts (or mind wan-
dering) as attention is paid to the task, and the DMN deac-
tivation is greater during more difficult or more engaging
tasks and thought to be necessary for optimising task per-
formance (McKiernan et al., 2003; Arsalidou et al., 2013;
Howard-Jones et al., 2016). Studies of brain metabolism
using blood flow SPECT and glucose metabolism PET
have demonstrated profound reductions in the regions of
the DMN including midline and lateral inferior parietal
lobes of LBD patients (O’Brien et al., 2014). We hypothes-
ised that in LBD, the increased deactivation of the DMN
was due to the tasks being found more difficult by the
subjects, owing to their cognitive and attentional deficits.
Our aim in this report was to investigate more thor-
oughly the association between response times in the LBD
patients, and the relative timing of regional brain activity
to see if delayed activation could play a role in the slow
responses seen in the task. In particular, we wished to
look at the latency and magnitude of the BOLD signal.
Specifically, we hypothesized that
a. the BOLD task positive network activations would be
delayed in LBD relative to controls, increasingly so
with harder condition, reflecting cognitive slowing;
b. in both groups, the DMN deactivation would increase
with harder condition, and that the deactivation would
overall be greater in LBD, reflecting their finding the
task more difficult;
c. there would not be differences in DMN deactivation
latency between conditions, as the deactivation occurs
at the start of task, and thus is not dependent on
difficulty.
MATERIALS AND METHODS
Participants
Subjects were the 32 Lewy body dementia (LBD) and 23
control subjects included in our previous study (Firbank
et al., 2016). Participants were recruited prospectively from
people aged over 60 with mild to moderate dementia with
a Mini-Mental State Examination (MMSE) score >12 from
a local community-dwelling population of participants
who had been referred to local old age psychiatry and
neurology services. Healthy controls were selected from
friends and spouses of participants included in this and
previous studies. The study was approved by the local
ethics committee and written consent was obtained from
all subjects.
Diagnosis of probable dementia with Lewy bodies, and
Parkinson’s disease with dementia was made independently
by two experienced clinicians using the revised Interna-
tional Consensus Guidelines for dementia with Lewy bodies
(McKeith et al., 2005) and diagnostic criteria for Parkinson’s
disease dementia (Emre et al., 2007), respectively. In accor-
dance with our previous report, these two groups were com-
bined into a LBD group. Cognitive function was tested using
the Cambridge Cognitive Examination (CAMCOG, maxi-
mum score 105) and the MMSE (maximum score 30). Con-
trol participants in the study demonstrated no evidence of
dementia (from history and score >80 on CAMCOG). Exclu-
sion criteria for all participants included contra-indications
for MR imaging, moderate to severe visual impairment, pre-
vious history of alcohol or substance misuse, significant
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neurological or psychiatric history, moderate to severe cere-
bral small vessel disease, focal brain lesions on brain imag-
ing, or the presence of other severe or unstable medical
illness.
Before undergoing a scanning session and formal in-scan
testing with the ANT, participants were familiarized with
the task, and it was verified that they could perform it cor-
rectly (task accuracy> 70%). All LBD patients were scanned
whilst taking their usual anti-parkinsonian medications and
in an “ON” motor state, typically 1–3 h after last dose.
Task
The task is described in detail in our previous report and
is summarized in Supporting Information, Figure S1. Briefly,
the task was based on the ANT (Fan et al., 2002) with a mod-
ified target component. On each trial, participants were
shown a cue, followed by four arrowheads, and had to indi-
cate the direction of the majority. The four arrowheads were
either all pointing the same direction (congruent), or one of
the arrows pointing the opposite direction (incongruent).
The incongruent arrow appeared either on the end of the
row (easy incongruent) or as one of the middle two (hard
incongruent). Hence, the easy incongruent task had three
congruent arrows in a row (unilateral flanker effect),
whereas the hard task had only two (bilateral flanker effect).
Behavioral contrasts were defined as (a) executive
effect5mean RT of the incongruent (easy and hard) trials
minus congruent trials and (b) conflict effect5mean RT of
the hard incongruent minus easy incongruent trials.
Neuroimaging Data Acquisition
Participants were scanned on a 3 T whole body MR scan-
ner (Achieva scanner; Philips Medical System, the Nether-
lands), with body coil transmission and eight channel head
coil receiver. Images acquired included a standard whole
brain structural scan (3DMPRAGE, sagittal acquisition, slice
thickness 1.0 mm, in plane resolution 1.03 1.0 mm; TR5 8.3
ms; TE5 4.6 ms; flip angle5 88; SENSE factor5 2). fMRI
data were collected with a gradient-echo (GE) echo planar
imaging (EPI) sequence (TR5 1.92 s; TE5 40 ms; field of
view (FOV)5 192 3 192 mm2 64 3 64 matrix size, flip angle
908, 27 slices, slice thickness 3 mm, slice gap 1 mm) with 156
volumes (5 min). We collected between four and six runs of
fMRI data while participants performed the attention task.
We excluded those runs with <2/3 correct responses, as
performance per run worse than this was not significantly
different from chance.
fMRI Analysis and Statistics
We used SPM8 (http://www.fil.ion.ucl.ac.uk/spm/) for
all image analysis. As described previously (Firbank et al.,
2016), the fMRI data were motion corrected and normalized
to MNI space via alignment with the T1 scan and the
DARTEL toolbox (Ashburner, 2007). A high pass filter of
128 s was used, and serial correlations were removed with
SPM’s AR(1) model.
Runs with >3 mm or >38 head motion were excluded. We
did not perform any interpolation or “scrubbing” of bad image
volumes. To investigate possible influences of data quality, we
calculated the mean and maximum absolute angular and
translational motion between frames (Peraza et al., 2015). We
also calculated standardized DVARS—the per-image standard
deviation of the temporal derivative of the data (Power et al.,
2012) using Tom Nichols’s script (http://www2.warwick.ac.
uk/fac/sci/statistics/staff/academic-research/nichols/scripts/
fsl/DVARS.sh) and determined the mean and maximum
over all volumes in each run.
The general linear model (GLM) in SPM was used to
conduct a whole-brain analysis of the fMRI data. We
created a design matrix using an impulse function with
onset time of the events (cues and targets with correct
responses). Missed targets and incorrectly responded to
targets were combined as an extra column in the design
matrix. These events were convolved with the canonical
hemodynamic response function (HRF), and the first
derivative of the HRF was also included to model varia-
tion in onset latency. The six parameters from the motion
correction for each functional run were included in the
design matrix as covariates of no interest. The regressors
were fitted to the fMRI data to produce beta estimates for
each regressor.
To further investigate the variation in BOLD with RT
within conditions, we performed a GLM with the addition
of parametric modulation; for each of the 3 task conditions,
an additional variable was included consisting of the HRF
onset intensity for each trial modulated by the RT for that
trial.
We used the formula of Henson et al (Henson et al.,
2002) to determine BOLD latency from the first derivative
of the HRF.
BOLD latency5 231:78= 11exp 3:13beta 2=beta 1ð Þð Þ21:78
where beta_1 and beta_2 are the estimates of the HRF and
its first derivative, respectively. This was calculated on a
voxelwise basis from the SPM beta images using an in-
house Matlab script (available on https://www.nitrc.org/
projects/sigmoidal_dt/).
We performed all analysis using regions of interest (ROI)
as defined previously (Firbank et al., 2016), taken from the
incongruent vs congruent contrast derived from all partici-
pants (dementia patients and healthy controls). The activa-
tion regions comprised a number of distinct clusters, with
some connection between clusters. They were manually
divided into distinct anatomical regions based on the clus-
ters (mid frontal, lateral frontal, insula, parietal, occipital),
and the deactivations into frontal (medial anterior) and pos-
terior (mostly posterior cingulate). These ROIs are shown in
Supporting Information, Figure S2 and Table S1. In addition,
we defined a motor area region from the combination of pre
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and post central gyrus regions from the AAL atlas (Tzourio-
Mazoyer et al., 2002). We utilized the MarsBaR SPM toolbox
(http://marsbar.sourceforge.net/) to extract mean values
for the BOLD contrast for the comparisons. The fMRI ROI
data were analyzed with a repeated measures ANOVA,
with each region investigated separately. Greenhou-
se–Geisser correction for nonsphericity was used for within
subject tests.
The SPSS (version 23, IBM) package was used to calcu-
late all statistics. In order to control for multiple compari-
sons in the ROI analysis, we used a Bonferroni correction
(factor of 9, giving an adjusted P< 0.0056).
RESULTS
Table I shows the subject demographics. There were no
significant differences in age, sex, or years of education
between the LBD and control participants. As previously
reported, (Firbank et al., 2016) RT were overall longer in
LBD (congruent RT5 1125 ms, SD 262 ms; easy incongru-
ent RT 1521 ms, SD 391 ms; hard incongruent RT 1800 ms,
SD 486 ms) vs control (congruent RT5 714 ms, SD 121 ms;
easy incongruent RT5 1005 ms, SD 217 ms; hard incon-
gruent RT5 1084 ms, SD 265 ms), with an increased exec-
utive/conflict RT effect of 200 ms. After exclusion of fMRI
runs with excess motion or poor responses, 6 runs were
included for 21/23 controls and 24/32 LBD; 5 runs for 2
control and 5 LBD; and 4 runs for 3 LBD (no significant
group difference in number of runs v2 52.13, P5 0.12).
There were no group differences in mean or maximum
translational movement (Table I). The mean angular
motion was slightly greater in the DLB group, but there
were no differences in the maximum angular movement.
The maximum and mean of the DVARS measure did not
differ between groups.
The results from the BOLD analysis are shown in Tables II
and III and Figure 1. For the BOLD amplitude, the repeated
measures ANOVA showed an overall effect of condition (as
expected from the ROI definition), with an effect of group
only on the DMN regions (significant in pDMN after Bonfer-
roni correction), consistent with the increased deactivation
of the DMN in the LBD group. For the latency (Table III),
however, there was a significant effect of group (with LBD
having a longer BOLD latency) for all but the DMN and
midfrontal regions. The motor area showed an effect of con-
dition on latency, with BOLD latency increasing from con-
gruent to easy-incongruent to hard-incongruent paralleling
the increase in RT in these conditions. Occipital regions had
a similar effect of condition on latency, as well as demon-
strating a significant interaction between group and condi-
tion, with the incongruent trials having relatively increased
latency for the LBD group. There were also significant inter-
actions (P 5 0.04, not surviving Bonferroni correction)
between condition and group for the BG region for both
latency and amplitude, the midfrontal for BOLD amplitude,
and the insula for BOLD latency. These interactions were all
of greater increase in BOLD amplitude and latency with the
harder conditions for LBD.
Supporting Information, Tables 2–4 shows the repeated
measures ANOVA results from the SPM analysis includ-
ing the RT parametric modulation. The results for the
amplitude and latency were similar to the original analy-
sis, with both DMN ROIs showing an effect of group on
BOLD amplitude, but no difference in latency, whilst
latency differences are still present for the insula, parietal
TABLE I. Demographics and clinical scores
Controls (N5 23) LBD (N5 32)
Between-group
differences (P value)
Age 76.3 (5.5) 75.0 (6.4) T535 0.76; P5 0.45
Sex male:female 16:7 27:5 v25 1.7; P5 0.2
Education years 11.7 (2.3) 10.5 (2.5) T535 1.9; P5 0.06
Duration (years) cognitive decline - 3.33 (2.07)
Cholinesterase Inhibitors 0 (0%) 27 (84%) -
Ldopa equivalent dose - 683.9 (450.1) [N5 21]
Positive DAT scan - 10/11 (91%)
UPDRS 1.3 (1.7) 19.06 (8.0)
MMSE 29.1 (0.9) 23.4 (3.8)
CAMCOG 96.8 (3.6) 76.7 (12.6)
Mean xyz motion (mm) 0.139 (0.04) 0.145 (0.08) T535 0.33; P5 0.74
Max xyz motion (mm) 0.602 (0.27) 0.618 (0.31) T535 0.21; P5 0.84
Mean angular motion (8) 0.062 (0.012) 0.088 (0.060) T535 2.07; P5 0.043
Max angular motion (8) 0.463 (0.28) 0.491 (0.28) T535 0.36; P5 0.72
Mean DVARS 1.36 (0.14) 1.36 (0.19) T535 0.01; P5 1.0
Max DVARS 4.32 (1.76) 3.85 (1.18) T535 1.18; P5 0.24
CAMCOG, Cambridge Cognitive Examination; MMSE, Mini-Mental State Examination; UPDRS, Unified Parkinson’s disease rating
scale.
DVARS per-image standard deviation of the temporal derivative.
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and occipital regions. For the RT parametric modulator of
BOLD magnitude, there were no significant differences
between groups or conditions, but there was an overall
significant effect, with longer RT within each condition
being associated with increased BOLD in the task positive
ROIs, and with increased deactivation in the pDMN (and
trend in the fDMN).
As a secondary analysis we also investigated the poten-
tial effect of levodopa, by looking at Spearman correlations
between the levodopa equivalent dose and the BOLD
activity and latency in all regions and conditions. Signifi-
cant correlations (not surviving Bonferroni correction)
were seen only in latency during easy incongruent for
midfrontal (q520.36, P5 0.043) and insula (q520.35,
P5 0.048) ROI. There were no significant correlations in
the LBD group between UPDRS motor score and reaction
time, BOLD amplitude or latency. There were also no sig-
nificant differences between those LBD patients taking
cholinesterase inhibitors vs not in response time or BOLD
amplitude or latency.
To investigate the potential effect of group differences in
data quality, we repeated the analysis in Tables II and III
using only those participants with all 6 runs, and with
mean angular and translational motion within 3SD of the
control group (21/23 controls, and 18/32 LBD). This pro-
duced qualitatively similar results, with the only difference
being that the fDMN had an effect of condition on
BOLD latency (F2,745 4.1; P5 0.021) although this was not
significant after Bonferroni correction.
DISCUSSION
Overall, our findings suggest that in this attention task,
the LBD group have slower cognitive processing, with
task related BOLD activations in the parietal, occipital,
Figure 1.
Plot of BOLD latency and activation magnitude against reaction
time to illustrate the repeated measures analysis presented in
Tables II and III, for the ROIs in the (A) motor cortex, (B) parie-
tal lobe, (C) posterior default mode network (pDMN), and (D)
occipital lobe. The 3 points per group (from left to right) are
the congruent, easy, and hard incongruent conditions. Solid
symbols are BOLD latency in seconds (on the left-hand axis)
and empty symbols are BOLD magnitude (on the right-hand
axis, with the dashed lines). The total range of the x-axes is the
same for all subplots. [Color figure can be viewed at wileyonli-
nelibrary.com]
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frontal, insula and motor cortex starting later in LBD com-
pared to controls. In contrast, the deactivations in the
DMN regions seemed to start at the same time regardless
of task or group, and were maintained until a response
was made.
As we previously reported (Firbank et al., 2016), analysis
of the reaction time data showed that the LBD group
were both slower overall, (congruent RT T535 7.0; P< 0.001)
and disproportionately slower for harder tasks (incon-
gruent–congruent RT T535 3.9, P< 0.001) compared to con-
trols. There was no significant correlation between UPDRS
motor score and reaction time, suggesting lack of a direct
influence of motor problems on the responses. The analysis
of the ROI data from the SPM analysis (Tables II and III)
showed that the overall amplitude of the task positive BOLD
activations increased with difficulty, but not across group.
However, the latency of the BOLD response was greater in
the LBD for most of the ROIs. In the second SPM analysis,
controlling for the effect of RT within condition (Supporting
Information, Tables 2–4), the same general pattern was seen,
and in addition, a number of regions (insula, parietal, BG,
and occipital) also showed an interaction between condition
and group, such that the harder conditions had relatively
increased latency for the LBD compared to controls. These
results suggest that the increased RT in the LBD group is a
result of delayed onset of task related cognitive activity, and
hence slower processing. These regions are all affected in
LBD, with metabolic reductions in the occipital and parietal
lobes (Firbank et al., 2017; Kantarci et al., 2012), reports of
reduced grey matter in the insula (Blanc et al., 2016; Xu
et al., 2016) and cholinergic (Maze`re et al., 2017) and dopa-
minergic (O’Brien et al., 2009) alterations in the BG.
For the default mode network regions, however, a differ-
ent effect was seen. The BOLD onset latency did not differ
either with task difficulty, or between LBD and controls. The
magnitude of the deactivation was significantly different
between groups and condition, but in the parametric modu-
lator analysis, (Supporting Information, Table S4) which
found a significant modulatory effect of the RT on the mag-
nitude of the pDMN deactivation (increased RT associated
with greater deactivation), there was no difference in the
modulation between groups or conditions, implying that the
increased BOLD deactivation in LBD and harder conditions
was simply an effect of more prolonged cognitive process-
ing. Altogether, this suggests that the BOLD deactivation is
initiated at the start of each trial, and lasts until the end of
the task related cognitive processing.
The relationship between DMN deactivation and task per-
formance is dependent upon the nature of the task. Increases
in DMN activity are present during self-reflection; in mem-
ory tasks, deactivation of the DMN has been associated with
better encoding (where deactivation represents suppression
of internal thoughts, and greater attention on the task), but
worse recall (as activation of the DMN is required for recall)
(Daselaar et al., 2009). In general, for externally oriented
tasks, more difficult, attention demanding tasks have greater
deactivation of the DMN (Andrews-Hanna, 2012) which is
in keeping with our observations. So for an individual, for
tasks of a fixed difficulty, increased deactivation is likely to
be associated with shorter RT, while increasing difficulty
will be associated with increased deactivation and longer
RT. Unlike AD, where there is dysfunctional behavior of the
DMN (Anticevic et al., 2012; Firbank et al., 2016), our find-
ings here suggest that in LBD, the DMN is fundamentally
intact, showing deactivations during externally directed
behavior, with the magnitude of the deactivation in keeping
with the duration of the trials. The primary difference in the
DMN in LBD is that the deactivations are more profound,
which we ascribe to slower cognitive functioning elsewhere
in the brain. Our findings are in agreement with a previous
study, which found normal DMN activity, but altered func-
tional connectivity in the frontal and parietal lobes of DLB
(Franciotti et al., 2013). Similarly, in an analysis on the group
presented here (Kobeleva et al., 2017), we found reduced
connectivity between the ventral attention network and
dorsal attention network in LBD, with normal connectivity
of the DMN.
Slower cognition or bradyphrenia is a significant feature
of Lewy body diseases, and has been reported in dementia
free Parkinson’s disease subjects, controlling for bradykine-
sia (Sawamoto et al., 2002). Visual inspection time, which
does not have a motor component, has been found to be sig-
nificantly increased in Parkinson’s disease (Johnson et al.,
2004), and DLB (Bailon et al., 2010), suggesting that visual
processing is slower in Lewy body disease. Using neuroim-
aging, slower cognitive processing in Parkinson’s disease
has been associated with abnormal caudate perfusion,
(Sawamoto et al., 2007) and dopamine changes in the cau-
date and anterior cingulate have been linked with reaction
time (Jokinen et al., 2013) and working memory deficits in
Parkinson’s disease (Sawamoto et al., 2008). In keeping with
these neuroimaging reports in Parkinson’s disease, we
observed an interaction between BOLD magnitude and
group (Table II) in the mid frontal (including anterior cingu-
late) and basal ganglia regions such that the LBD had a dis-
proportionate increase in BOLD for harder conditions. The
caudate is involved in motor and cognitive initiation (Grahn
et al., 2008) and thus our findings are consistent with the
argument that disruption of the dopaminergic system via
the basal ganglia may be, in part, responsible for the slow
processing in LBD. However, the cholinergic system, which
influences attention and information processing speed
(Schneider et al., 2015; Wesnes and Warburton, 1984) is also
dysfunctional in LBD, and the cholinergic projections from
the brainstem to the thalamus and basal ganglia have been
found to be particularly affected in LBD compared to AD
(Kotagal et al., 2012).
Dopaminergic treatment can alter brain network function,
and levodopa has been reported to enhance functional connec-
tivity (Krajcovicova et al., 2012) of the posterior DMN. Our
patients were all scanned whilst taking their dopaminergic
anti-parkinsonism medication (although not all participants
r Firbank et al. r
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were on these agents), which may have affected responses
and DMN deactivation. However, recent studies in cogni-
tively intact Parkinson’s disease have found no effect of levo-
dopa on choice reaction times, despite improvements to
bradykinesia (Michely et al., 2012; Michely et al., 2015). Simi-
larly, the reported effect of levodopa is to restore to normality
a reduced DMN deactivation, rather than to enhance it (Dela-
veau et al., 2010; Spetsieris et al., 2015). Thus we believe that
the slow RT and greater DMN deactivation we see are
unlikely to be due to dopaminergic medication. Cholinergic
drugs have been reported to improve attentional function
(Bentley et al., 2003; Broks et al., 1988; McKeith et al., 2000),
largely by modulating frontoparietal networks (Bentley et al.,
2011; Bokde et al., 2009; Risacher et al., 2013). Most of the LBD
patients were taking cholinesterase inhibitor medication,
which has been shown to result in faster RT in Parkinson’s dis-
ease (Rowan et al., 2007), so may have reduced response laten-
cies in subjects, although we did not see any differences in
those patients taking such medication compared to those not
on these agents. Further studies are needed to investigate the
role of cholinergic and dopaminergic medication in cognitive
tasks in LBD to help clarify the neuronal origin of cognitive
slowing.
Examining the occipital lobe BOLD latency, we observed
a significant interaction between condition and group
(Table III), with the LBD patients having increased latency
for the harder conditions. One would expect the onset of
BOLD activation of the occipital lobe to occur in response
to stimulus presentation, as the visual system processes
the incoming event (Corbetta and Shulman, 2002). We pos-
tulate that the increased latency in the occipital lobe with
harder conditions is due to top–down influences, (Siemann
et al., 2016) as the target is probed more carefully in the
conflict conditions, leading to an ongoing rise in occipital
activity. This increase was present in both groups, but was
more marked in the LBD patients, perhaps reflecting inef-
ficient visual processing, and/or top–down visuo-
attentional deficits. If so, this inefficient processing would
also contribute to the slower response time in the LBD
subjects. Further analysis using techniques like dynamic
causal modeling (Friston et al., 2003) is required to investi-
gate how the relative timing of different regional activity
contributes to cognitive slowing in LBD.
In the motor cortex, as expected, the latency of the
BOLD response varied with condition (with the latency
increasing for the conditions with longer RT) and group
(with the LBD group having later latency than controls).
This is in keeping with later initiation of motor activity for
those more difficult trials with resultant longer reaction
times. The delayed start of motor activity in LBD also
adds support to the idea that the longer reaction times in
LBD are partly due to slower cognition rather than motor
impairments/bradykinesia.
Limitations include that we did not correct for slice
timing effects in our fMRI processing. However, the slice
prescription was the same for all subjects, so the relative
position of each slice in the brain should be approximately
the same for all. In particular, the posterior DMN region
(which showed no change in BOLD latency) is immedi-
ately adjacent to the parietal region (which did show a sig-
nificant difference). In addition, the BOLD signal is an
indirect measure of neuronal activity, and delays in the
timing of the BOLD may reflect, for instance, differences
in cardiovascular responses between LBD patients and our
comparison subjects. Many LBD subjects were taking
cholinergic and/or dopaminergic medication, which may
have altered brain connectivity. The posterior DMN
regions show a decrease in resting glucose metabolism
and blood flow in PD, which is more marked in subjects
with cognitive decline (Bohnen et al., 2011; Firbank et al.,
2017; Huang et al., 2007). Owing to the highly connected
nature of the region, it remains unclear whether cognitive
related changes reflect intrinsic pathology, or alterations in
response to change elsewhere. Although our results found
that the latency of the BOLD activation was increased in
LBD, we cannot unambiguously ascribe the RT delays to
this presumed neuronal delay. In particular, we found dif-
ferences in latency in the basal ganglia, which are involved
in both motor and cognitive functions. Further studies
investigating functional connectivity are required to deter-
mine how the basal ganglia interacts with other regions in
this task, to clarify to what extent the slow RT is due to
BG input to motor regions, and how much to its involve-
ment in cognitive slowing.
Overall, our finding that brain activation in LBD was
relatively delayed across regions involved in the task sug-
gests that the slow reaction times in LBD in the attention
network task are a result of slower cognitive processes
rather than purely bradykinesia. In comparison, the task-
related deactivation of the default mode network in LBD
seems essentially intact, but the longer decision time leads
to a greater deactivation. Our data showing an interaction
of basal ganglia activity with group/task are in keeping
with a possible role for dysfunction of the dopaminergic
and/or cholinergic system in slower cognition.
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